Our Pricing

Weight Loss Meds with Next Day Delivery Available

Published on: June 03, 2026

Searching for weight loss meds with next day delivery UK options? Cured Pharmacy offers a comprehensive range of MHRA-licensed weight loss treatments, from advanced GLP-1 injections like Mounjaro and Wegovy to proven oral medications like Orlistat. Every prescription requires a free clinical assessment by our UK-registered prescribers, with discreet packaging and transparent pricing from £135.00.

How Prescription Weight Loss Medications Work

Modern weight loss medications work through distinct mechanisms to support sustainable weight reduction when combined with lifestyle changes. GLP-1 receptor agonists like tirzepatide and semaglutide mimic natural gut hormones that regulate appetite and blood glucose, whilst lipase inhibitors like orlistat reduce dietary fat absorption in the digestive system [1].

Tirzepatide, the active ingredient in Mounjaro, represents the latest advancement as the first dual GIP/GLP-1 receptor agonist licensed in the UK. In the SURMOUNT-1 trial, participants achieved an average body weight reduction of 20.9% over 72 weeks on the 15mg maintenance dose — substantially higher than earlier single-pathway treatments [1]. Semaglutide (Wegovy) demonstrated average weight loss of 14.9% in the STEP 1 trial, whilst liraglutide (Saxenda) showed 8% reductions in clinical studies [2][3].

Orlistat-based medications work differently by blocking approximately 30% of dietary fat from being absorbed, making them suitable for patients who prefer oral tablets or have contraindications to injectable treatments [4]. All prescription weight loss medications require ongoing clinical supervision and are most effective alongside reduced-calorie diets and increased physical activity.

Comparing GLP-1 Injections: Mounjaro, Wegovy and Saxenda

Wegovy contains semaglutide, a selective GLP-1 receptor agonist administered once weekly via pre-filled FlexTouch pens. The treatment follows a structured dose escalation schedule from 0.25mg to a maintenance dose of 2.4mg over 16-20 weeks, minimising gastrointestinal side effects during titration [2]. Clinical trials showed 86.4% of participants maintained at least 5% weight loss at 68 weeks.

Saxenda uses liraglutide, an earlier-generation GLP-1 agonist requiring daily subcutaneous injection. Starting at 0.6mg daily, the dose increases weekly to a maximum of 3mg. Whilst requiring more frequent administration than weekly alternatives, Saxenda offers a lower entry price point and remains clinically effective for patients who achieve adequate response [3].

Mounjaro (Tirzepatide) — Dual-Action Treatment

Mounjaro activates both GIP and GLP-1 receptors, producing greater weight reduction than single-pathway alternatives in head-to-head trials. The once-weekly injection starts at 2.5mg and titrates up to a maximum maintenance dose of 15mg, with dosing adjustments made every four weeks based on tolerability [1]. At Cured Pharmacy, Mounjaro is available from £135.00 following clinical assessment.

Orlistat Medications: Xenical, Alli and Generic Options

Orlistat is a lipase inhibitor that prevents approximately one-third of dietary fat from being digested and absorbed. Available in 120mg prescription strength (Xenical and generic orlistat) and 60mg over-the-counter formulations (Alli, Orlos), it provides an alternative for patients unsuitable for injectable treatments [4].

The 120mg prescription dose is taken three times daily with meals containing fat, whilst the 60mg strength follows the same schedule. Clinical studies demonstrate average weight loss of 5-10% when combined with a reduced-calorie, lower-fat diet. Side effects are primarily gastrointestinal and directly related to dietary fat intake — patients consuming high-fat meals experience increased oily stools and urgency [4].

At Cured Pharmacy, generic orlistat 120mg starts from £135.00 Xenical from £135.00, and lower-dose Orlos from £135.00. Your UK prescriber will recommend the appropriate strength based on your BMI, medical history, and treatment goals during your free online consultation.

Who Can Access Prescription Weight Loss Treatment

Our UK-registered prescribers conduct comprehensive medical assessments before approving any weight loss medication. The online consultation takes under three minutes and covers your weight history, current medications, pre-existing conditions, and previous weight loss attempts. This ensures treatment safety and appropriateness for your individual circumstances.

Patients already taking certain medications may require dose adjustments or alternative treatments. GLP-1 receptor agonists can delay gastric emptying, potentially affecting oral medication absorption, whilst orlistat may reduce absorption of fat-soluble vitamins and some medicines. Our clinical team reviews all potential interactions during your assessment to ensure safe, effective treatment.

Clinical Eligibility Criteria

NICE guidelines recommend prescription weight loss medications for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related comorbidities such as type 2 diabetes, hypertension, or obstructive sleep apnoea [5]. GLP-1 treatments require additional assessment for contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease.

What to Expect: Treatment Timeline and Results

Clinical trials show peak weight loss occurs between 60-72 weeks of continuous treatment, with most reduction happening in the first 6-12 months. NICE recommends reviewing treatment response at 6 months — if you haven't achieved at least 5% weight loss, your prescriber may suggest alternative options or additional lifestyle interventions [5].

Orlistat produces more modest but consistent results, with most weight loss occurring in the first six months. Clinical data shows patients lose approximately 50% more weight with orlistat plus lifestyle changes compared to lifestyle changes alone [4]. Regular follow-up consultations ensure your treatment remains effective and appropriately dosed throughout your weight loss journey.

Initial Response and Dose Titration

GLP-1 treatments begin with low starter doses that gradually increase over several weeks. This titration schedule minimises common side effects like nausea and allows your body to adjust to the medication. Most patients notice reduced appetite within the first week, though significant weight loss typically becomes apparent after 4-8 weeks of treatment [1][2].

Why Choose Cured Pharmacy for Weight Loss Treatment

As a fully registered UK pharmacy (GPhC 9012511) under superintendent pharmacist Tarun Kumar (GPhC 2233073), we dispense only genuine, MHRA-licensed medications. Our transparent pricing shows exact costs before you begin your consultation — no hidden fees or surprise charges at checkout.

Every prescription requires clinical approval from our UK-registered prescribers, ensuring treatment safety and regulatory compliance. Your free online assessment takes under three minutes, with prescriptions reviewed the same day. Once approved, medications are dispensed from our UK pharmacy with next day delivery available, all in discreet, unmarked packaging.

We guarantee the lowest prices in the UK on prescription weight loss medications. If you find a lower price at another registered UK pharmacy for the same medication and dose, we'll match it. Our clinical team remains available throughout your treatment for dose adjustments, side effect management, and ongoing support via phone on (+44) 116 4646009.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
4. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
5. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and lifestyle changes.